In the case of emerging technologies such as stem cells and nanotechnology, inventions are frequently claimed in product-by-process format when the exact physical differences of the end products are not yet known. Recent Supreme Court precedent in Japan has created turmoil for patent applicants seeking to pursue product-by-process claims, though they remain a well-accepted claiming format in the U.S.
Join us for an interactive roundtable discussion of comparative claim drafting strategies for protecting these types of inventions in the U.S. and Japan, as well as opportunities for enforcing, challenging, and defending these types of claims.
